使用凝血酶的合成显色底物对抗凝血酶进行测定。 - Suppr

Suppr

超能文献

The assay of antithrombin using a synthetic chromogenic substrate for thrombin.

作者信息

Blombäck M, Blombäck B, Olsson P, Svendsen L

出版信息

Thromb Res. 1974 Nov;5(5):621-32. doi: 10.1016/0049-3848(74)90052-8.

DOI:10.1016/0049-3848(74)90052-8

PMID:4445986

Abstract

摘要

相似文献

The assay of antithrombin using a synthetic chromogenic substrate for thrombin.使用凝血酶的合成显色底物对抗凝血酶进行测定。

Thromb Res. 1974 Nov;5(5):621-32. doi: 10.1016/0049-3848(74)90052-8.

A simple amidolytic method for the determination of functional active antithrombin III.一种用于测定功能性活性抗凝血酶III的简单酰胺水解法。

Scand J Clin Lab Invest. 1976 Jan;36(1):109-12. doi: 10.1080/00365517609068026.

[Physiological inhibitors of thrombin and thrombin synthesis].[凝血酶及凝血酶合成的生理抑制剂]

Folia Haematol Int Mag Klin Morphol Blutforsch. 1973;99(2):212-22.

Methods for semi micro or automated determination of thrombin, antithrombin, and heparin cofactor using he substrate, H-D-Phe-Pip-Arg-p-nitroanilide-2HCl.使用底物H-D-苯丙氨酸-哌啶-精氨酸-对硝基苯胺-2HCl半微量或自动测定凝血酶、抗凝血酶和肝素辅因子的方法。

Clin Chim Acta. 1977 Sep 15;79(3):595-602. doi: 10.1016/0009-8981(77)90181-4.

Novel immunoenzyme assays for thrombin-antithrombin III and thrombin-alpha 2-macroglobulin complexes in plasma.血浆中凝血酶-抗凝血酶III及凝血酶-α2-巨球蛋白复合物的新型免疫酶测定法。

Ann N Y Acad Sci. 1986;485:184-98. doi: 10.1111/j.1749-6632.1986.tb34580.x.

[Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].[凝血酶、抗凝血酶、凝血酶 - 抗凝血酶复合物（TAT）]

Nihon Rinsho. 2004 Dec;62 Suppl 12:626-8.

Photometric assay of antithrombin III with a chromogenic substrate.用显色底物对抗凝血酶III进行光度测定。

Haemostasis. 1975;4(2):101-9. doi: 10.1159/000214093.

The rivanol method for the quantitative determination of antithrombin III in plasma.用于定量测定血浆中抗凝血酶III的利凡诺方法。

Thromb Diath Haemorrh. 1974 Jun 30;31(3):439-51.

Thrombin inhibitory activity of fractions obtained by gel filtration of antithrombin 3 deficient plasma.

Scand J Haematol. 1968;5(2):155-7. doi: 10.1111/j.1600-0609.1968.tb01731.x.

Assay of progressive antithrombin in plasma.血浆中进行性抗凝血酶的测定。

Thromb Diath Haemorrh. 1970 Oct 31;24(1):224-9.

引用本文的文献

Cytokine and coagulation characteristics of retrieved blood after arthroplasty.

Intensive Care Med. 1995 Dec;21(12):989-95. doi: 10.1007/BF01700660.

Electrode adsorption method for determination of enzymatic activity.

Med Biol Eng Comput. 1982 May;20(3):362-74. doi: 10.1007/BF02442806.

Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease.

Blut. 1983 Aug;47(2):93-103. doi: 10.1007/BF02482643.

Comparison of three methods for the estimation of plasma antithrombin.三种血浆抗凝血酶估计方法的比较

J Clin Pathol. 1980 May;33(5):438-44. doi: 10.1136/jcp.33.5.438.

Complex-formation and inhibition of urokinase by blood plasma proteins.血浆蛋白对尿激酶的复合物形成及抑制作用。

Biochem J. 1983 Oct 1;215(1):123-31. doi: 10.1042/bj2150123.

Arginine residues are critical for the heparin-cofactor activity of antithrombin III.精氨酸残基对于抗凝血酶III的肝素辅因子活性至关重要。

Biochem J. 1985 Oct 1;231(1):59-63. doi: 10.1042/bj2310059.

Increased thromboplastic potential in diabetes: a multifactorial phenomenon.

Klin Wochenschr. 1987 Jul 1;65(13):600-6. doi: 10.1007/BF01726667.

Associated von Willebrand disease as a possible cause of lack of thrombosis in an AT III abnormality (AT III Trento).

Blut. 1986 Jan;52(1):29-33. doi: 10.1007/BF00320139.

Determination of antithrombin activity by an amidolytic and a clotting procedure.通过酰胺水解法和凝血法测定抗凝血酶活性。

J Clin Pathol. 1979 Jan;32(1):21-5. doi: 10.1136/jcp.32.1.21.

Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.钙对凝血酶激活人凝血因子VIII/血管性血友病因子蛋白的某些影响。

J Clin Invest. 1977 Oct;60(4):819-28. doi: 10.1172/JCI108836.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验